Insulinlike growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers.
Insulinlike growth factor II (IGF-II) is a highly mitogenic fetal growth factor suspected of regulating the growth of a wide spectrum of tissues via an autocrine or paracrine mode of action or both. High steady-state levels of IGF-II RNA were detected in 45% of hepatocellular carcinomas (HCCs) arising from woodchuck livers with persistent woodchuck hepatitis virus (WHV) infection. Analysis of WHV RNA in the same HCCs revealed that HCCs with high levels of IGF-II RNA contained low or undetectable levels of WHV RNA and HCCs with low levels of IGF-II RNA contained high levels of WHV RNA. Integrated WHV DNA was present in HCCs from both groups, but viral DNA replicating forms were present, predominantly in HCCs with low levels of IGF-II. Several IGF-II RNAs, the most prominent of which were poly(A) species of approximately 3.75 and 1.1 to 1.3 kilobases, were detected only in precancerous nodules and HCCs. Levels of IGF-II were elevated two- to three-fold in the serum of woodchucks with chronic active hepatitis preceding the occurrence of HCC. Proliferation of a population of oval cells, which arise from portal tract regions in the liver, preceded the development of HCC and was a prominent feature of livers from which tumors with high levels of IGF-II occurred. The HCCs tended to have distinct histological features according to their growth factor status. Tumors with low levels of IGF-II were generally highly differentiated acinar-trabecular HCCs, whereas tumors with high levels of IGF-II were more anaplastic, with regions of fibrosis and fatty accumulation. A model to relate the pathology of WHV infection to oval cell proliferation and IGF-II expression in the development of these heterogeneous HCCs is presented.
Fu
X X
XX
Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461.
Su
C Y
CY
Lee
Y
Y
Hintz
R
R
Biempica
L
L
Snyder
R
R
Rogler
C E
CE
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000032:analysis / Q000209:etiology* / Q000473:pathology; D002455:Cell Division; D004279:DNA, Viral / Q000235:genetics; D006518:Hepatitis Viruses / Q000235:genetics; D006524:Hepatitis, Viral, Animal / Q000150:complications*; D007335:Insulin-Like Growth Factor II / Q000096:biosynthesis* / Q000235:genetics; D008099:Liver / Q000032:analysis / Q000473:pathology; D008113:Liver Neoplasms / Q000032:analysis / Q000209:etiology* / Q000473:pathology; D008392:Marmota; D009693:Nucleic Acid Hybridization; D011230:Precancerous Conditions / Q000473:pathology; D012313:RNA / Q000032:analysis*; D012367:RNA, Viral / Q000032:analysis; D013002:Somatomedins / Q000096:biosynthesis*; D014158:Transcription, Genetic
D004279:DNA, Viral; D012367:RNA, Viral; D013002:Somatomedins; D012313:RNA; D007335:Insulin-Like Growth Factor II